A new class of non-nucleoside reverse transcriptase inhibitors with a 6-vinylpyrimidine scaffold (1) has been found to inhibit HIV-1 reverse transcriptase (RT) by competition with the nucleotide substrate after binding to the non-nucleoside inhibitor binding pocket of the enzyme. Molecular modeling studies have been performed to elucidate their peculiar behavior
Unlike classical non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors (NNRTI; active site in b...
Of the different steps of the HIV replicative cycle, the reverse transcription step has received mos...
The reverse transcriptase (RT) of human immunodeficiency virus type 1 (HIV-1) is potently inhibited ...
How odd! A new class of non-nucleoside reverse transcriptase inhibitors with a 6-vinylpyrimidine sca...
How odd! A new class of non-nucleoside reverse transcriptase inhibitors with a 6-vinylpyrimidine sca...
How odd! A new class of non-nucleoside reverse transcriptase inhibitors with a 6-vinylpyrimidine sca...
How odd! A new class of non-nucleoside reverse transcriptase inhibitors with a 6-vinylpyrimidine sca...
HIV-1 reverse transcriptase (RT) inhibitors currently used in antiretroviral therapy can be divided ...
HIV-1 reverse transcriptase (RT) inhibitors currently used in antiretroviral therapy can be divided ...
HIV-1 reverse transcriptase (RT) inhibitors currently used in antiretroviral therapy can be divided ...
HIV-1 reverse transcriptase (RT) inhibitors currently used in antiretroviral therapy can be divided ...
HIV-1 reverse transcriptase (RT) inhibitors currently used in antiretroviral therapy can be divided ...
Fragment-based screening methods can be used to discover novel active site or allosteric inhibitors ...
How odd! A new class of non-nucleoside reverse transcriptase inhibitors with a 6-vinylpyrimidine sca...
A novel scaffold inhibiting wild type and drug resistant variants of human immunodeficiency virus ty...
Unlike classical non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors (NNRTI; active site in b...
Of the different steps of the HIV replicative cycle, the reverse transcription step has received mos...
The reverse transcriptase (RT) of human immunodeficiency virus type 1 (HIV-1) is potently inhibited ...
How odd! A new class of non-nucleoside reverse transcriptase inhibitors with a 6-vinylpyrimidine sca...
How odd! A new class of non-nucleoside reverse transcriptase inhibitors with a 6-vinylpyrimidine sca...
How odd! A new class of non-nucleoside reverse transcriptase inhibitors with a 6-vinylpyrimidine sca...
How odd! A new class of non-nucleoside reverse transcriptase inhibitors with a 6-vinylpyrimidine sca...
HIV-1 reverse transcriptase (RT) inhibitors currently used in antiretroviral therapy can be divided ...
HIV-1 reverse transcriptase (RT) inhibitors currently used in antiretroviral therapy can be divided ...
HIV-1 reverse transcriptase (RT) inhibitors currently used in antiretroviral therapy can be divided ...
HIV-1 reverse transcriptase (RT) inhibitors currently used in antiretroviral therapy can be divided ...
HIV-1 reverse transcriptase (RT) inhibitors currently used in antiretroviral therapy can be divided ...
Fragment-based screening methods can be used to discover novel active site or allosteric inhibitors ...
How odd! A new class of non-nucleoside reverse transcriptase inhibitors with a 6-vinylpyrimidine sca...
A novel scaffold inhibiting wild type and drug resistant variants of human immunodeficiency virus ty...
Unlike classical non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors (NNRTI; active site in b...
Of the different steps of the HIV replicative cycle, the reverse transcription step has received mos...
The reverse transcriptase (RT) of human immunodeficiency virus type 1 (HIV-1) is potently inhibited ...